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Background: Neuronal migration involves the directional migration of immature neurons. During much of the
migration period these neurons are polarized with defined leading and trailing processes. Stk25 has been shown to
bind to the LKB1 activator STRAD and regulate neuronal polarization and dendritogenesis in an opposing manner
to Reelin-Dab1 signaling. It is not known, however, whether Stk25 controls neuronal migration, a key developmental
process regulated by Reelin-Dab1 signal transduction.
Findings: Here we find that while constitutive Stk25 deficiency does not lead to neuronal phenotypes, acute
reduction by either Cre-mediated gene inactivation or by knockdown causes a developmental neuronal migration
error. Furthermore, we find that knockdown of LKB1, STRAD and GM130, molecules that have previously been
implicated with Stk25, causes similar aberrations in neuronal migration.
Conclusions: Loss of Stk25 function early in development likely leads to functional compensation for its roles in
neuronal development. Stk25 regulates neuronal positioning, possibly as part of the LKB1-STRAD-Stk25-GM130
pathway that was previously shown to be important for neuronal polarization.
Keywords: Neuronal migration, Brain development, Reelin, Dab1, Sok1, Ysk1, LYK5Findings
Introduction
The STE20 family serine/threonine kinase Stk25 (also
Ysk1, Sok1) has been shown to regulate hippocampal
neuronal polarity and dendritogenesis in an opposing
fashion to the Reelin-Dab1 signaling pathway. Stk25 par-
ticipates in cell polarity by interacting with STRADα
(also LYK5), an activator of the serine-threonine kinase
LKB1. LKB1 is an evolutionarily conserved Par4 homolog
central to cell polarity regulation in many cell types. A prior
study has shown that Stk25 knockdown hinders LKB1-
STRADα-regulated epithelial cell polarization whereas its
overexpression restores polarity defects observed in LKB1
knockdown neurons [1]. Furthermore, Stk25 opposes the
action of the Reelin-Dab1 signaling pathway to regulate
dendritogenesis and neuronal polarization. The Reelin-
Dab1 signaling pathway is best known for its role in orches-
trating brain lamination by regulating neuronal migration
and cell positioning [2]. The opposing relationship between* Correspondence: howellb@upstate.edu
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stated.Reelin-Dab1 and LKB1-STRAD-Stk25-GM130 signaling
raises the possibility that inactivating the latter may also
disrupt neuronal migration. Consistent with this hypothesis,
inactivation of the STRADα gene disrupts the development
of neuronal laminae [3,4], indicating an important role in
neuronal migration for this polarity signaling system.
The Reelin-Dab1 signaling pathway was identified
through the analysis of mouse mutants with very similar
phenotypes. The dab1 mutant mice and the Reeler
mutant, which fails to make or secrete the Reelin pro-
tein, have very similar lamination defects in the neocor-
tex, hippocampus and cerebellum, among other regions
of the central nervous system [5-8]. Mice with com-
pound homozygous mutations in the partially redundant
receptor genes ApoER2 and VLDLR also share this
phenotype [9]. It was subsequently shown that the
Reelin ligand binds to the extracellular domains of
ApoER2 and VLDLR and clusters them, leading to the
tyrosine phosphorylation of Dab1 [10,11]. Tyrosine-
phosphorylated Dab1 acts to nucleate signaling com-
plexes, particularly with the adaptor proteins Crk and
CrkL that ultimately regulate cell surface cadherin ex-
pression [12-15]. Consistent with a role for cadherins onl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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leads to migration defects in embryonic neurons, and N-
cadherin overexpression partially rescues defects caused
by dab1 gene disruption [14,15].
STRADα is a pseudokinase that binds to LKB1, re-
cruits it to the cytoplasm, stabilizes it and leads to its ac-
tivation [16]. LKB1 phosphorylates and activates over a
dozen downstream kinases [17], which are involved in
cell proliferation, polarization and migration, in addition
to energy metabolism [18]. One branch of this pathway
that is relevant to neuronal positioning is the AMPK
pathway that regulates mTOR signaling [3]. LKB1 acti-
vates AMPK, which phosphorylates and activates
mTSC2, blocking mTOR function and subsequently
inhibiting S6 kinase activation. Patients with homozy-
gous recessive STRADα mutations develop polyhydram-
nios, megalencephaly, and symptomatic epilepsy (PMSE)
[19]. PMSE shares some similarities to tuberous sclerosis
caused by inactivating mutations in TSC2, including cor-
tical dysplasia, epilepsy and neurons with abnormal
morphology [3].
Stk25 has been shown to regulate polarized migration
in cultured cells, and this activity is regulated through
its interactions with GM130 [20], a ubiquitously
expressed Golgi-shaping protein. GM130 has been
shown to regulate tethering of ER-derived vesicles with
the Golgi [21,22]. GM130 knockdown, like Stk25 and
LKB1 knockdown, causes loss of axonal initiation, the
first step of neuronal polarization [1]. The Golgi is be-
lieved to play an important role in cell polarization
[23-25]. GM130, Stk25 and LKB1 knockdown causes
Golgi dispersion [1], which could reduce its ability to
contribute to cell polarity. Stk25 overexpression did not
rescue the Golgi dispersion or polarity defects caused by
GM130 knockdown, possibly suggesting that GM130
acts downstream of Stk25 [1]. The role of this pathway
and the Golgi apparatus in neuronal migration is not
known.
Here we made use of a novel Stk25 conditional mutant
mouse to both constitutively and acutely inactivate Stk25
during brain development to assess its role in neuronal
positioning. In addition, by in utero knockdown, we
examined the roles of LKB1, STRADα and GM130 in
this process.
Results
To determine whether Stk25 has a role in neuronal posi-
tioning, we generated a conditional Stk25 mouse model
by floxing exons 4 and 5 (Figure 1A). The floxed allele
supported normal Stk25 protein expression (Figure 1B).
Cre-mediated excision is predicted to cause a frameshift
and translational termination (Figure 1A). As a first step
in the analysis, we generated an Stk25 knockout line by
inactivating the Stk25 gene in the germline by transgenicCre expression. Western blots of brain lysates from mice
that are homozygous for this inactivated Stk25 allele
(Stk25−/−) had no detectable Stk25 protein expression at
postnatal day (P) 0, suggesting that this represents a null
allele (Figure 1B).
The Stk25−/− mice were born at the expected Mendel-
ian frequency. These animals were indistinguishable
from littermates based on body size or behavior. Since
we had previously shown that Stk25 knockdown reduces
axon initiation in vitro and in vivo, we examined the
major nerve tracts in adult mice. We found no signifi-
cant reduction in size of the major nerve bundles by
standard histological staining (data not shown). It is pos-
sible that with more extensive analysis, subtle changes in
nerve tracts might be uncovered. However, the brain
histology clearly was at odds with our expectations from
our in utero knockdown study, in which we found ap-
proximately 40 percent of neurons failed to extend an
axon [1]. In addition, no significant disruption of layers
was revealed by immunostaining for the layer V-VI marker
Ctip2, or the layer II- IV marker Satb2 (Figure 1C,D). This
was consistent with the histology, which showed no obvi-
ous disruption of lamination in the cortex, hippocampus
or cerebellum (data not shown).
The discrepancy between our previous results based
on Stk25 knockdown [1], which indicated a role for
Stk25 in neuronal polarization and axon initiation, and
the lack of a phenotype in the nerves tracks of Stk25 −/−
mice led us to investigate whether there was compensa-
tion for the loss of Stk25 gene function, which has been
reported for other knockouts. If this was the case, we
reasoned that acute loss of Stk25 might cause a neuronal
positioning phenotype. To examine this we knocked
down Stk25 expression in utero by electroporating a
construct that expresses a previously validated shRNA
[1] at embryonic day (E) 14.5. The position of GFP-
labeled neurons at E17.5 was compared between brains
electroporated with the knockdown and an empty vector
(Figure 2A,B). In the Stk25 knockdown brains a high
percentage of neurons stalled in the intermediate zone,
whereas in the empty vector (EV) control they migrated
into the cortical plate.
The above results are consistent with the hypothesis
that the inactivation of Stk25 needs to be acute in order
to observe a neuronal phenotype. However, there are
other possibilities that could explain the discrepancies
between the knockdown and knockout phenotypes. For
instance, perhaps the predicted residual 87 N-terminal
Stk25 peptide generated from the exon 4 to 5-deleted
Stk25 gene sustains some function. It is also formally
possible that the phenotype is revealed only during a de-
velopmental window and not observed in adults. To test
these possibilities, we asked if acute inactivation of
homozygous floxed Stk25 (Stk25fl/fl) would produce a
Figure 1 Generation of Stk25 conditional mice. A) Exons 4 and 5 were floxed by homologous recombination, which introduced a PGK-EM7
neo drug-selectable marker. The Frt-flanked marker was removed by FLP-mediated recombination. Cre-mediated recombination removes exons 4 and
5, resulting in a frameshift and termination in exon 6. The product of homologous recombination (homologous), FLP-mediated recombination (FLP)
and Cre-mediated recombination (Cre) are shown. B) Stk25 protein levels were measured by western blotting (anti-Stk25; [1]) in brain lysates of P0 mice
with the indicated genotype. The Stk25fl/fl (fl/fl) allele is fully functional for Stk25 expression and the germline expression of Cre generated a null allele
with no detectable Stk25 expression in the homozygous state (−/−). C) The positions of Satb2-positive layer II-IV and Ctip2-positive layer V-VI neurons
are evident in the neocortex of two-month-old wild-type mice. D) An indistinguishable pattern of lamination was observed in the Stk25−/− mice.
Cortical layers are indicated to the left of the images (Bar 50 μm).
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lyzing the migration of Stk25−/− neurons in the E14.5 to
E17.5 time frame would reveal differences from wild-type.
Interestingly, the GFP-labeled neurons in Stk25fl/fl
mice that were acutely exposed to Cre expression stalled
their migration in the intermediate zone (Figure 3B). In
contrast, expression of CRE-GFP in Stk25fl/+ embryonic
neurons did not cause an arrest in neuronal migration.
These neurons migrated similarly to wild-type neurons
expressing GFP (Figure 3B,C). This suggests that expres-
sion of the CRE-GFP fusion protein does not cause erro-
neous migration and that half the normal levels of Stk25
are sufficient to sustain neuronal migration. Similarly
Stk25−/− neurons labeled with GFP migrated normally
(Figure 3A,C). This shows that there was a distinct dif-
ference in neuronal migration between animals where
the Stk25 gene was inactivated from the time of concep-
tion and those where Stk25 was inactivated acutely at
E14.5 in a subset of neurons.Stk25 has previously been linked to STRADα and
GM130 through protein-protein interactions. In addition,
Stk25 was shown to partially rescue Golgi fragmentation
and loss of axon initiation defects observed in LKB1
knockdown neurons [1]. We thus investigated whether
LKB1, STRADα or GM130 plays a similar role in neuronal
positioning by knocking down these molecules at E14.5
with vectors expressing the respective shRNAs and co-
expressing GFP. The position of GFP- labeled neurons
was analyzed in the brains of E17.5 pups.
The knockdown of LKB1, STRADα and GM130 re-
duced the number of GFP- tagged neurons in the cor-
tical plate and increased the number that were observed
in the intermediate zone, albeit to different extents.
Interestingly LKB1 knockdown caused the greatest in-
crease in neurons in the intermediate zone, though the
brain-specific knockout of this gene did not cause an ap-
parent neuronal positioning error [26]. Our findings
with STRADα are consistent with other studies that
Figure 2 Knockdown of Stk25 and signaling partners leads to anomalous neuronal migration. A) Knockdown or control (empty) vectors
were electroporated into E14.5 mouse cortex and the position of GFP-tagged neurons were examined at E17.5. B) The knockdown of Stk25, LKB1,
STRADα or GM130 decreased the number of neurons in the upper cortical plate (CP) and increased the number of neurons held up in the
intermediate zone (IZ) as compared to empty vector control (EV) electroporated cells (*P <0.0001 ANOVA with Tukey-Kramer post-hoc test).
Ventricular zone/Subventricular zone (VZ/SVZ).
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tioned neurons. The finding that GM130 is required for
neuronal positioning is the first evidence to our know-
ledge that expression of a Golgi protein is involved in
neuronal migration.
Discussion
In this study, we demonstrate that Stk25 and molecules
with a physical or functional link to Stk25 have a role in
neuronal positioning during brain development. We deter-
mined that acute knockdown of Stk25 by shRNA produced
a migration disruption, which was surprising given the lack
of neuronal position phenotype in adult Stk25−/− mutant
mice. Furthermore, we found that the acute inactivation of
the Stk25 gene at E14.5 by Cre-mediated excision led toaberrations in neuronal positioning that are apparent by
E17.5. In contrast, the GFP-labeled neurons in the Stk25−/−
mice did not have an obvious positional phenotype in
the developing brain. This suggests that when Stk25 is
inactivated for an extended period prior to neuronal
exit from the proliferative zone there is some form of
compensation. We confirmed results that knockdown
of STRADα and LKB1 caused erroneous migration
[4,27] and demonstrate that this is qualitatively similar
to the defects caused by Stk25 deficiency (Figure 2A,B).
We also find similar migration phenotypes when the
Golgi-organizing protein GM130 is knocked down
(Figure 2A,B). This suggests that in addition to working
together during neuronal polarization as previously
shown [1], the gene products Stk25, LKB1, STRADα
Figure 3 Acute inactivation of the conditional Stk25 allele by Cre causes a neuronal migration anomaly. A) The electroporation of
GFP-encoding DNA into the developing cortex of E14.5 embryos marks neurons that have entered the upper portion of the cortical plate (CP) by
E17.5. B) In contrast, Stk25fl/fl neurons that express GFP-Cre fail to populate the cortical plate and instead many are located in the intermediate
zone. GFP-Cre-expressing neurons in the Stk25fl/+ mice migrate in a fashion similar to wild-type GFP-expressing neurons. C) Quantification of the
GFP-expressing neurons in the indicated regions of the neocortex demonstrates that Stk25fl/fl neurons exposed to Cre (4) are statistically more
likely to be in the intermediate (IZ) or subventricular (SVZ) zones and less likely to be in the cortical plate than Stk25fl/+; Cre-GFP (3), Stk25−/−;
GFP (2) or wild-type; GFP (1) neurons (*P = 0.001, **P <0.0001 ANOVA with Tukey-Kramer post-hoc test).
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neuronal positioning.
Discrepancies between the knockdown and the knock-
out phenotypes have been observed for several genes in-
cluding: dcx [28,29], dclk [30,31], APP [32,33], and PKCδ
[34,35]. These discrepancies have been attributed to
compensation for the loss-of-gene function; however,
this has not been experimentally tested. Here we show
that depending on the mechanism of inactivation of theStk25 conditional allele, we either observed no pheno-
type or a dramatic phenotype (compare Figure 3B with
Figure 3A). The acute inactivation of the Stk25 gene by
Cre-mediated recombination led to an accumulation of
neurons in the intermediate zone (Figure 3B,C), very
similar to the Stk25 knockdown phenotype (Figure 2A,B).
In contrast, tagging migrating neurons in constitutive
Stk25−/− mice with GFP did not reveal a neuronal migra-
tion disruption (Figure 3A,C). Furthermore adult Stk25−/−
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only when the Stk25 gene is inactivated acutely is a role in
neuronal migration apparent. It remains to be determined
how the cells compensate for Stk25 loss-of-function; for
instance, are related genes upregulated or is compensa-
tion more complex, involving the different effectors of
Stk25 signaling?
Another difference between the acute and the consti-
tutive inactivation of Stk25 is that the acute inactivation
was limited to a subset of neurons surrounded by wild-
type cells; the knockout eliminated Stk25 expression in
every cell. It is possible that Stk25-null cells, in a null
environment have a competitive advantage for migration
compared to mutant cells in a wild-type environment.
However this seems unlikely.
Inactivation of the Reelin-Dab1 pathway also causes
neuronal positioning errors that have been documented
in knockout and RNA interference experiments [36]. In-
activation of dab1 at E16 causes a failure to enter the
cortical plate at E20 and E21 when control cells are con-
centrated in this region. The similarity of the neuronal
migration phenotypes, however, should not be seen as
evidence that Stk25 and Reelin-Dab1 signaling have
synergistic effects. Similarities in neuronal positioning
effects have also been observed for knockdown of
MARK2/par-1 and DCX, which have the opposite effect
on microtubule stability [37]. The inactivation of either
causes neuronal migration failures, but the combination
of the mutations partially rescues the migration pheno-
types. It remains to be determined if inactivation of the
genes encoding the players of the Reelin-Dab1 pathway
and Stk25 simultaneously would increase or decrease
the severity of the observed migration defect.
STRADα is thought to regulate neuronal positioning
through mTor regulation [4,19]. Accordingly, the AMPK
branch of the pathway phosphorylates and inhibits TSC2
leading to mTOR suppression and reduced activity of S6
kinase and decreased phospho-S6. Consistent with this
model, both PMSE and tuberous sclerosis patients have
elevated levels of phospho-S6. Similarly, STRADα defi-
ciency led to an aberrant increase in phosph-S6 in cul-
tured neural progenitor cells [4]. Together, this suggests
that failure to inactivate mTor is one of the underlying
biochemical defects in the neurons with inactivating
mutations in STRADα.
The evidence for other molecules on the pathway is
not as straightforward, however. The brain-specific
knockout of LKB1 has no apparent lamination defect
despite very obvious defects in axonal production [26],
and knockdown of LKB1 at E18 did not cause neuronal
migration defects [38]. In contrast, both a previous study
and ours demonstrate neuronal positioning errors in
LKB1-deficient neurons by in utero knockdown at E14
[27]. Perplexingly, a brain-specific deletion of the genesencoding the two catalytic subunits of AMPK (AMPKα1
and AMPKα2) had no noticeable effects on neuronal
migration [39]. Thus, work is required to determine the
interplay between downstream effectors of the LKB1
signaling pathway and their effects on neuronal position-
ing. Intriguingly, mTor is predicted to be upregulated
by Reelin-Dab1 signaling through AKT suppression of
TSC2 [40,41]. It may therefore represent a point of con-
vergence of Reelin-Dab1 and Stk25 signaling.
Another downstream target of these pathways that
may be involved in regulating neuronal positioning is
GM130. This study represents the first evidence to our
knowledge that a Golgi protein is involved in regulating
neuronal migration. Work remains to determine how
the Golgi may participate in the process. It has previ-
ously been shown that the local positioning of the Golgi
or Golgi outposts influences Golgi growth and branching
[42,43]. It has been postulated that dendritic branching
may influence neuronal positioning by facilitating neur-
onal anchoring to a particular lamina [44]. The position
of the centrosome/Golgi complex also has important
roles in neuronal polarity regulation. Neuronal morph-
ology, polarity and Golgi/centrosome position have been
shown to be dynamic during neuronal migration [45,46].
Thus alterations in the Golgi, which hinder the normal
dynamic transport of cargo proteins, may perturb the
migratory path of the migrating neuron.
Conclusions
Compensation for developmentally early Stk25 loss-of-
function seems likely since we observe dramatic pheno-
types when the loss was acute in neuronal progenitors at
E14.5. Examining the null animals, which have the same
Cre-mediated gene rearrangement, with the same method
of in utero labeling of neurons did not show any detect-
able position anomaly. Neither were there any lamination
or nerve tract defects observed in the Stk25−/− adults,
which would be expected from the migration anomalies
and the loss of axon initiation observed by acute Stk25
knockout or Stk25 knockdown (Figure 1; [1]). Given the
previously documented physical interactions between
Stk25, GM130 and STRAD and the similarities of the
neuronal positioning phenotypes of the Stk25, LKB1,
STRAD, and GM130 knockdowns, it seems likely they
act on the same pathway to regulate neuronal migration.
Further studies are required to resolve the interplay be-
tween the Reelin-Dab1 and Stk25 pathways to determine
how they interface to regulate neuronal positioning during
development.
Methods
Generation of the Stk25 floxed and knockout mice
Exons 4 and 5 of the Stk25 gene were floxed and a
PGK-EM7 neomycin cassette flanked by Frt sites was
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generate the knockout vector (Figure 1A). The vector was
electroporated into C57BL/6-129/Sv hybrid ES cells at the
University of Connecticut transgenic core (Farmington
CT, USA). Cells that had undergone homologous recom-
bination were identified by PCR. Recombinant ES cells
were injected into blastocysts that were then transplanted
by standard techniques into pseudopregnant dams. The
PGK-EM7 neomycin resistance cassette was removed by
breeding the chimeric founder mice with Flp-expressing
transgenic mice leaving sole Frt and loxP sites in the in-
tron after recombination (Figure 1A). The Flp transgene
was outbred by backcrossing with wild-type C57BL/6
mice. The resultant animals are referred to here as hetero-
zygous or homozygous floxed Stk25 (Stk25fl/+ or Stk25fl/fl,
respectively) mice. Cre-mediated excision of exons 4 and 5
is predicted to cause the frameshift-termination of transla-
tion in exon 6 after translating 87 residues of the Stk25 N-
terminus (Figure 1A).
Heterozygous Stk25 knockout (Stk25−/+) mice were gen-
erated by breeding Stk25fl/+ and the transgeneic germ-
line-deleter, Meox2-Cre (B6.129S4-Meox2 < tm (Cre)Sor;
Jackson Labs, BarHarborME, USA)mice. Progeny that were
positive for the Stk25 gene modification were backcrossed
with C57BL/6 to outbreed theMeox2-Cre transgene.
To distinguish the conditional allele from the wild-type,
the following primers that flank the 5′ loxP site were used:
P1 (tcagagaggccttttctcca) and P2 (gccagcctggtctacagatt).
The PCR products were 293 bp for the wild-type allele and
375 bp for the mutant. To identify the allele generated by
the excision of exons 4 and 5, P1 was used in conjunction
with primers that flank the Frt site, P3 (cccatttttaatggcca-
cac) and P4 (gggggacctacaggaacatt). The wild-type and mu-
tant alleles produce 468 and 345 bp products, respectively.
Mice used for this manuscript were either on a mixed
C57BL/6-129/SV (backcrossed to C57BL/6 at least four
times) or Swiss Webster backgrounds. For in utero elec-
troporation with Cre (Stk25fl/+, Stk25fl/fl; Figure 3B,C)
the mice were C57BL/6-129/SV. The null allele was
backcrossed four times onto the Swiss Webster back-
ground for histological analysis (Figure 1C, data not
shown) and in utero electroporation with GFP (Stk25−/−,
wt; Figure 3A,C). Finally wild-type Swiss Webster mice
were used for in utero electroporations with shRNAs
(Figure 2A).
All mice were treated ethically and humanly according
to National Institutes of Health (NIH) care and use guide-
lines following protocol (#267), which was approved by
the Committee for the Humane Use of Animals at SUNY
Upstate Medical School.
Heterozygous Stk25 knockout (Stk25−/+) mice were
generated by breeding Stk25fl/+ and the transgenic
germline-deleter, Meox2-Cre (B6.129S4-Meox2 < tm (Cre)
Sor; Jackson Labs) mice. Progeny that were positive forthe Stk25 gene modification were backcrossed with
C57BL/6 to outbreed the Meox2-Cre transgene.DNA constructs
For the in utero electroporations a modified version of
pLL3.7 was used that has a CMV enhancer/chicken
β-actin promoter-driving GFP and the U6-promoter
driving shRNA synthesis (pLC) [1]. The shRNAs used to
knock down expression of Stk25, LKB1, and GM130
have been described previously [1]. The shRNA to knock
down STRADα was generated to the target sequence 5′-
gcagcaaccttagcatgatta-3′ (NM028126; bases 533–553).
The STRADα shRNA reduced by over 80% the expres-
sion of Myc-tagged murine STRADα in HEK293T cells
(data not shown).
The pCAG-Cre: GFP vector was obtained from Addgene
(www.addgene.org) and was initially constructed by the
Cepko lab [47].Histological analysis
For immunohistochemistry, brains were perfused with
4% paraformaldehyde in Pagano solution (250 mM su-
crose, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid pH 7.4, 2.5 mM Magnesium acetate, 2.5 mM
KCl), post-fixed overnight and then cryopreserved in
40% sucrose in PBS for two days. The brains were sec-
tioned (40 μm thick) using a cryostat (CM1900; Leica
Biosystems, www.leicabiosystems.com). Sections were
immunostained in 3% BSA and 1% ovalbumin in Tris-
buffered saline (TBS) containing 0.5% Triton X-100 with
anti-Ctip2 (rat IgG, Abcam, Cambridge MA, USA) and
anti-Satb2 (mouse IgG, SatbA4B10; Abcam) overnight
followed by anti-rat IgG and anti-mouse immunodetec-
tion (Alexa 568, Alexa 488, respectively; Invitrogen,
www.lifetechnologies.com/us/en/home/brands/invitro-
gen.html). Slides were mounted with Vectashield (Vector
Labs, Burlingame CA, USA) containing DAPI (Sigma,
St. Louis MO, USA). Brain sections were magnified with
a 10X objective and images were collected by fluo-
rescence microscopy (ImagerA2, Zeiss, Oberkochen,
Germany) with a digital black and white CCD camera
(QImaging, Redwood City CA, USA). Several sections
were collected for each brain slice and these were
stitched together using NIS-elements software (Nikon,
Tokyo, Japan). Images were pseudocolored and inten-
sities adjusted using Photoshop software (Adobe, San
Jose CA, USA).
For histological staining (not shown), brains were fixed
in 70% ethanol, dehydrated with 100% ethanol, clarified
with xylenes and imbedded in paraffin. Coronal sections
were taken throughout three brains of each genotype
(wild-type, Stk25−/+ and Stk25−/−) every 10 μm and
stained with hematoxylin and eosin for analysis.
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4% paraformaldehyde in Pagano solution and post-fixed
for 2 to 3 h. Brains were then embedded in 10% porcine
gelatin (Sigma, St. Louis MO, USA) and post-fixed in 4%
paraformaldehyde/Pagano’s for 24 h. Brains were sec-
tioned on a VT100S vibratome (50 μm thick; Leica
Biosystems, www.leicabiosystems.com). GFP- positive
sections were collected, immuno-stained with chicken
anti-GFP antibody (Invitrogen) and mounted on slides
with DAPI containing Vectashield (Vector Lab, Burlin-
game CA, USA) for visualization. Bin counts for GFP-
positive cells were collected from three sections from
each of three independent electroporated brains for the
indicated samples.
Western blotting
Lysates were prepared from P0 mouse brains of the desig-
nated genotypes in RIPA buffer (20 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1% Nonidet P40, 2 mM EDTA, 1% sodium
deoxycholate, 0.1% SDS, 5 mM 2-mercaptoethanol, 50 mM
sodium fluoride, phosphatase inhibitor cocktail 1 (Sigma, St.
LouisMO, USA), 1mMphenylarsine oxide (Sigma, St. Louis
MO, USA) and protease inhibitors (complete mini EDTA-
free; Roche Applied Science, Penzberg, Germany). Samples
were sonicated for 5 seconds with a probe sonicator to shear
DNA and stored on ice for 10 min to extract proteins. Sam-
ples were clarified by centrifugation at 20,000 × g to remove
insolublematerial. Samples were normalized for total protein
content using a bicinchoninic acid (BCA) kit (Pierce, Rock-
ford IL, USA). Equal amounts of protein mixed with twice
concentrated sample buffer (4% SDS, 20% sucrose, 10% gly-
cerol, 125 mMTris–HCl pH 6.8, 100 mM dithiothreitol, and
0.02% bromophenol blue) were resolved on NuPAGE™
Novex 4-12% Bis-Tris polyacrylamide gels (Invitrogen, www.
lifetechnologies.com/us/en/home/brands/invitrogen.html),
transferred to Immobilon P (Millipore, Billerica MA, USA)
and immunoblotted to detect endogenous Stk25 (anti-Stk25
[1]; Santa Cruz Biotechnology, Santa Cruz CA, USA) essen-
tially as described previously [48].
In utero electroporations
In utero electroporations were performed on E14.5 em-
bryos as described in previous studies with minor modi-
fications [26,36]. To introduce indicated DNA vectors
into neuronal progenitors located in the cortical ven-
tricular zone of indicated genotype of mice, DNA vectors
(1 μl of 1 mg/mL, 0.01% FastGreen (Sigma, St. Louis
MO, USA) in PBS) were injected into the lateral ventri-
cles of E14.5 embryos in the uteri of deeply anesthetized
dams [36]. Tweezertrodes were placed on either side of
the uterus at the level of the injected DNA and four
100 msec square pluses of 40 mV current separated by
100 msec intervals were applied to the head of the em-
bryo using an ECM 830 electroporator (BTX, HarvardApparatus, Holliston MA, USA). GFP-positive embryos
were perfused at E17.5 and prepared for histological
analysis.
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